Acral Melanoma in Chinese: A Clinicopathological and Prognostic Study of 142 cases
- PMID: 27545198
- PMCID: PMC4992860
- DOI: 10.1038/srep31432
Acral Melanoma in Chinese: A Clinicopathological and Prognostic Study of 142 cases
Abstract
Acral melanoma (AM), as a peculiar subgroup of melanoma, is rare in Caucasians but has higher incidence in Asians. Large series of study on AM with clinicopathological features and prognostic factors is still limited, especially in Asian population. We retrospectively collected clinical, pathological and follow-up data of 142 AM cases. All patients were Chinese, with the age ranging from 24 to 87 years (mean 62.0; median 62.0). The Breslow thickness of primary lesions ranged from 0.6 to 16.3 mm (mean 4.9; median 3.7). 85.9% of the patients had acral lentiginous histologic subtype. Plantar was the most frequently involved site, followed by heels. Statistically, duration of the lesion before diagnosis (≤2.5 years), Breslow thickness >4.0 mm (T4), high mitotic index (>15 mm(-2)), presence of vascular invasion, regional lymph node metastasis at diagnosis and pathologic stage (II/III/IV) were found to be independent prognostic factors in both univariate and multivariate analyses. The prognosis of AM in Chinese is extremely poor. Our 5- and 10-year disease-specific survival (DSS) rates were 53.3% and 27.4%, respectively. Therefore, AM in Asians represents a more biologically aggressive melanoma subtype and is thought to carry a worse prognosis when compared with other races or cutaneous melanomas in other anatomic sites.
Figures



Similar articles
-
Acral Lentiginous Melanoma: A Clinicoprognostic Study of 149 Cases at a Single Institution.Am Surg. 2024 Apr;90(4):600-606. doi: 10.1177/00031348231204915. Epub 2023 Sep 26. Am Surg. 2024. PMID: 37751620
-
Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma.Arch Pathol Lab Med. 2021 Aug 1;145(8):943-952. doi: 10.5858/arpa.2020-0308-OA. Arch Pathol Lab Med. 2021. PMID: 33290520
-
Plantar melanoma is associated with certain poor prognostic histopathological factors, but not correlated with nodal involvement, recurrence, and worse survival.Clin Transl Oncol. 2018 May;20(5):607-612. doi: 10.1007/s12094-017-1755-6. Epub 2017 Sep 25. Clin Transl Oncol. 2018. PMID: 28948477
-
Metastatic acral lentiginous melanoma in a tertiary referral center in Switzerland: a systematic analysis.Melanoma Res. 2018 Oct;28(5):442-450. doi: 10.1097/CMR.0000000000000465. Melanoma Res. 2018. PMID: 29847461
-
Recent advancements in the diagnosis and treatment of acral melanoma.J Zhejiang Univ Sci B. 2024 Feb 15;25(2):106-122. doi: 10.1631/jzus.B2300221. J Zhejiang Univ Sci B. 2024. PMID: 38303495 Free PMC article. Review.
Cited by
-
A Narrative Review of the Evolution of Diagnostic Techniques and Treatment Strategies for Acral Lentiginous Melanoma.Int J Mol Sci. 2024 Sep 27;25(19):10414. doi: 10.3390/ijms251910414. Int J Mol Sci. 2024. PMID: 39408752 Free PMC article. Review.
-
Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective Study.Oncol Res. 2019 Mar 29;27(4):495-501. doi: 10.3727/096504018X15331163433914. Epub 2018 Aug 3. Oncol Res. 2019. PMID: 30075827 Free PMC article.
-
Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.Br J Dermatol. 2022 Jun;186(6):977-987. doi: 10.1111/bjd.21026. Epub 2022 Mar 25. Br J Dermatol. 2022. PMID: 35042273 Free PMC article.
-
Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.Front Immunol. 2021 Jun 4;12:680407. doi: 10.3389/fimmu.2021.680407. eCollection 2021. Front Immunol. 2021. PMID: 34149718 Free PMC article. Review.
-
Characterization of highly active mutational signatures in tumors from a large Chinese population.medRxiv [Preprint]. 2023 Nov 4:2023.11.03.23297964. doi: 10.1101/2023.11.03.23297964. medRxiv. 2023. Update in: Cancer Res Commun. 2025 Aug 8. doi: 10.1158/2767-9764.CRC-24-0496. PMID: 37961450 Free PMC article. Updated. Preprint.
References
-
- Dai B. et al.. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences. Human pathology 44, 1472–1478 (2013). - PubMed
-
- Cormier J. N. et al.. Ethnic differences among patients with cutaneous melanoma. Archives of internal medicine 166, 1907–1914 (2006). - PubMed
-
- Shaw J. H. & Koea J. B. Acral (volar-subungual) melanoma in Auckland, New Zealand. The British journal of surgery 75, 69–72 (1988). - PubMed
-
- Cascinelli N. et al.. Acral lentiginous melanoma. A histological type without prognostic significance. The Journal of dermatologic surgery and oncology 20, 817–822 (1994). - PubMed
-
- Ridgeway C. A., Hieken T. J., Ronan S. G., Kim D. K. & Das Gupta T. K. Acral lentiginous melanoma. Archives of surgery 130, 88–92 (1995). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical